Qube Research & Technologies Ltd
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 1729829
LONDON, X0
Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$127,383,056
+$64,233,228 QoQ
Shares Held
8,809,340
+98.6% QoQ
Ownership
2.81%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. FOLD ranks #2 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in FOLD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $127,383,056 | 8,809,340 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $63,149,828 | 4,434,679 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,786,682 | 1,749,579 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,865,400 | 3,466,911 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,735,288 | 1,070,501 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,564,994 | 803,078 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,379,004 | 690,918 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $605,020 | 60,990 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,553,956 | 556,363 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $2,263,679 | 204,119 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $784,980 | 64,290 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $731,520 | 70,069 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $339,674 | 35,568 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $139,288 | 14,449 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $258,253 | 26,139 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $432,890 | 30,658 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $155,535 | 10,314 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||